<html>
<head>PUBMED IDs for AOP2</head>
<body bgcolor='#C5F0F2'><h1>AOP2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11677226/'>Transcriptional regulation of the antioxidant protein 2 gene, a thiol-specific antioxidant, by lens epithelium-derived growth factor to protect cells from oxidative stress.</a> October 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11677220/'>Risk stratification for periampullary carcinoma in patients with familial adenomatous polyposis: does theodore know what to do now?</a> October 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11677215/'>Inactivating mutations of KILLER/DR5 gene in gastric cancers.</a> October 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11677206/'>Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.</a> October 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11677205/'>Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations.</a> October 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11677194/'>Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1.</a> October 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11677152/'>The human homologue (PEG3) of the mouse paternally expressed gene 3 (Peg3) is maternally imprinted but not mutated in women with familial recurrent hydatidiform molar pregnancies.</a> October 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11677150/'>The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage.</a> October 26  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/25545244/'>Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.</a> June 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25545243/'>Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.</a> September 9  2014<br></body></html>
